Test 1 Contraception Flashcards
Contraception Epidemiology
- 49% of all pregnancies in the US are unintended
- Of the intended pregnancies the outcomes are
- Birth (80%)
- Fetal Loss (20%)
- Unintended pregnancies result in
- Birth (about 50%)
- Fetal Loss (about 10%)
- Abortion (about 40%)
Methods of contraception used by women 15-44 years of age in the US
- From Highest use to lowest
- Not using contraception
- Sterilization (Tubal ligation is more common than vasectomy)
- Pill
- Condom
- IUD (increased from 2nd to last in 2002 to fifth in 2013)
- Progestin Injection
- Withdrawal Method
- Other
Contraception Effectiveness
- Measured by failure rates in the first year of use:
- Typical use = % of couples using the method for 1 year, but not perfectly (not correctly and/or not consistently)
- More common
- Perfect use = % of couples who use the method perfectly for 1 year (correctly and consistently)
- Typical use = % of couples using the method for 1 year, but not perfectly (not correctly and/or not consistently)
- Generally speaking, hormonal methods are more effective than non-hormonal methods (with the exception of copper IUD)
Contraception Effectiveness: Greatest to worst
- Effectiveness Greatest to worst
- Implanon
- Male sterilization
- Mirena
- Female sterilization
- Paragard
- Depo
- Pill, patch, ring
- diaphragm, sponge
- male condom
- female condom
- Withdrawal
- Fertility based awareness methods
- spermicides
- No method
Non-Hormonal Forms of Contraception
- Lactational Amenorrhea
- Fertility Awareness-Based Methods
- Barrier techniques
- Spermicides
- Sponge
Lactational Amenorrhea
- Non-hormonal form
- Exclusive breast-feeding
- When they are not exclusively breast fed, milk production decreases and menstruation resumes
- Amenorrheic (no periods occurring) first 2 months some bleeding is ok
- Infant less than 6 months old
Fertility Awareness-Based Methods
- Non-hormonal method
- Beads, bracelets, apps
- Monitor cervical mucus, breast tenderness – signs of ovulation
Barrier techniques
- Non-hormonal Method
- Diaphragm
- Cerivical cap
- Male Condome
- Female Condom
Diaphragm
- Non-hormonal method
- Bigger, more flexible
- Cover the cervix
- Must add spermicide
- Must be fitted for the appropriate size
- Can be placed 6 hours before needed
- Must be left in for 6 hours after intercourse
Cervical Cap
- Non-hormonal Method
- Smaller, harder – like a thimble
- Same as diaphragm
- Cover the cervix
- Must add spermicide
- Must be fitted for the appropriate size
- Can be placed 6 hours before needed
- Must be left in for 6 hours after intercourse
Male condom
- Non-hormonal method
- Latex (most common)
- Oil-based drug formulations and lubricants can decrease the barrier strength of latex by 90% in 60 seconds
- Medicated creams can also decrease the barrier strength
- Impermeable to viruses
- Can be used with water-based lubricants
- Lambskin
- Not impermeable to viruses – can pass through
- May recommend for someone with a latex allergy
- Synthetic (usually polyurethane)
- Impermeable to viruses
- May recommend to someone with a latex allergy
- Can use an oil-based lubricant – will not degrade
Spermicides
- Non-hormonal Method
- nonoxynol-9 (only one in the US available)
- Foams, creams, suppositories, jellies, films
- Films, vaginal tablets
- If it is something that needs to be dissolved, it must be inserted ~30 minutes prior to be effectively absorbed
- May increase risk of HIV transmission
Sponge
- Non-hormonal method
- Contains 1 g of nonoxynol-9
- Acts partially as a barrier, partially as a spermicide
- Like a diaphragm or cervical cap – can be placed 6 hours before, and must be kept in for 6 hours after intercourse
General Principles of Combined Hormonal Contraceptives
- Estrogen- inhibits ovulation by suppressing FSH and LH by suppressing feedback loop
- 1 of 3 estrogens is used in combined hormonal contraceptives
- Ethinyl estradiol (EE) – most common
- Mestranol – gets converted to EE
- Estradiol valerate – newest; prodrug that is metabolized to estradiol
- Marketed as being better tolerated; may be better for clotting, but there are no studies to prove it
- High dose = 50 mcg
- Low dose = 30 – 35 mcg (most women start here)
- Ultra-low dose = 20 – 25 mcg
- 1 of 3 estrogens is used in combined hormonal contraceptives
- Progestin – Inhibits ovulation by suppressing LH surge, thicken cervical mucous, make endometrial thin.
- Progestins vary in their amount of progestational, estrogenic, and androgenic effect
1st generation progestins
- Norethindrone
- moderate estrogen, progestin, and andogen activity)
- Norethindrone acetate
- (moderate estrogen and androgen activity, high progestin activity)
- Ethynodiol diacetate
- moderate estrogen, high progestin, low androgen activity
2nd genertaion progestins
- More potent than 1st generation
- Norgestrel
- no estrogen, high progestin and androgen activiy
- Levonorgestrel
- no estrogen, very high progestin and androgen activity
3rd generation progestins
- Fewer androgenic and metabolic effects vs 1st generation
- Norgestimate
- no estrogen, mod progestin and androgen activity
- Desogestrel
- no-low estrogen, very high progestin, and mod androgen activity
Other progestins
- Antiandrogen effects
- Drosperenone
- no estrogen, no-low progestin, no androgen activity
- Dienogest
- no estrogen, no-low progestin, no androgen activity
Androgen activity
hair growth
- acne
- deepening of the voice
- pick one that doesn’t have androgen activity or even negative activity if the patient is showing signs of androgen activity already
- drosperenone would be a good one
- pick one that doesn’t have androgen activity or even negative activity if the patient is showing signs of androgen activity already
- Drosperenone – very similar to spironolactone – monitor K+
- Dienogest – newer agent – does not affect K+
Progestin prodrugs
- Norelgestromin (prodrug) – similar to norgestimate
- Found in the BC patch
- Etonogestrel (prodrug) – similar to desogestrel
- Found in the implant and vaginal ring
Combination Side effects
- Based on estrogenic, progestational, and androgenic components (estrogens have the most fatal side effects)
- Warning signals
- A = abdominal pain (ectopic pregnancy, gallbladder disease, clot in abdominal vein)
- C = chest pain (clot in the heart (MI) or lung (pulmonary embolism))
- H = headache (clot in the brain (stroke))
- E = eye problems (stroke)
- S = severe leg pain (DVT
- Warning signals
Combination Drug Interactions
- Rifampin – potent inducer
- May see a problem with broad-spectrum antibiotics (like tetracycline), but data doesn’t support this claim
- Still put the label on
- Enzyme inducers – carbamazepine, phenobarbital
- Drugs that alter GI mobility, or block absorption (cholestyramine)
- Drugs that affect K+ in patients taking Drosperenone (ACEi, spironolactone, NSAIDs)
Combination Monitoring
- Blood pressure – due to estrogen (increases 6-8mmHG)
- K+ – if the patient is on Drosperenone
Noncontraceptive benefits of combination contraception
- Relief from menstruation-related problems (less menstrual cramps, less ovulatory pain or mittelschmerz, less menstrual blood loss)
- Improvedin menstrual regularity
- Increased hemoglobin concentrations
- Improvement in acne
- Reduced risk of ovarian and endometrial cancer
- Reduced risk of ovarian cysts
- Reduced risk of ectopic pregnancy
- Reduced risk of pelvic inflammatory disease
- Reduced risk of benign breast disease
Considerations for Initiating Combined Oral Contraceptives (COC)
- Concomitant medical conditions
- Examinations before initiating Contraceptives
- Estrogen and progestin dose
- Monophasic vs phasic
- Cycle length
- Start date
Concomitant medical conditions
- U.S. Medical Eligibility Criteria for Contraceptive Use – 4 categories
- Category 1 – condition for which there is no restriction for the use of the contraceptive method
- Perfectly safe – no restrictions
- Category 2 – condition for which the advantages of using the method generally outweigh the theoretical or proven risks
- Generally considered safe
- Category 3 – condition for which the theoretical or proven risks usually outweigh the advantages of using the method
- Don’t recommend
- Category 4 – condition that represents an unacceptable health risk if the contraceptive method is used
- Don’t recommend
- Category 1 – condition for which there is no restriction for the use of the contraceptive method
Examinations before initiating Contraceptives
- Don’t need PAP Smear
- Don’t need pregnancy test but you have to be reasonably sure that the patient is not pregnant
- Needs blood pressure taken